LU80974A1 - BENZYLIDENIC DERIVATIVES - Google Patents
BENZYLIDENIC DERIVATIVES Download PDFInfo
- Publication number
- LU80974A1 LU80974A1 LU80974A LU80974A LU80974A1 LU 80974 A1 LU80974 A1 LU 80974A1 LU 80974 A LU80974 A LU 80974A LU 80974 A LU80974 A LU 80974A LU 80974 A1 LU80974 A1 LU 80974A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- compounds
- ether
- hydroxy
- compound
- dryness
- Prior art date
Links
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
- 150000001875 compounds Chemical class 0.000 description 29
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 150000002576 ketones Chemical class 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 7
- 239000003208 petroleum Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical class CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000003610 charcoal Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 235000013311 vegetables Nutrition 0.000 description 5
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 150000001340 alkali metals Chemical group 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 150000002825 nitriles Chemical class 0.000 description 4
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- -1 alkyl radicals Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- LFRHMTZYADABJZ-UHFFFAOYSA-N 1-(1,3-benzodioxol-5-yl)butan-2-amine;hydron;chloride Chemical group Cl.CCC(N)CC1=CC=C2OCOC2=C1 LFRHMTZYADABJZ-UHFFFAOYSA-N 0.000 description 1
- ONIKNECPXCLUHT-UHFFFAOYSA-N 2-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1Cl ONIKNECPXCLUHT-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229910016467 AlCl 4 Inorganic materials 0.000 description 1
- 101100006960 Caenorhabditis elegans let-2 gene Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical compound F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical group [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
JJ
**
I »La prison te invention concerne g es dérives bonzyliaén iques, berr i JThe prison of the invention relates to bonzyliaen drifts, berr i J
I !:préparation et leur application en thérapeutique.I!: Preparation and their application in therapy.
* » j Dans son brevet.luxembourgeois No 75 514 . la Demanderesse a aeorit les·composés répondant à la formule - - - °H ’ *-0-* »J In his Luxembourgish patent No 75 514. the Applicant aeorit the · compounds corresponding to the formula - - - ° H ’* -0-
c = N-C H- “CORc = N-C H- “COR
! x/ | n 2n • dans laquelle X^z et X^, qui sont identiques ou différents, représentent chacun, indépendamment l'un de l'autre, un atome d'hydrogène ou d'ha-!logène, notamment le chlore -ou le fluor, ou bien un radical méthy- 5 ! ! leou méthoxyle, n représente un nombre entier au moins égal à 1 et au plus égal à 10 et, R représente un radical hydroxyle, OM, NH2, NH (CK2) COOH,-NH (CH2)2 ~ COOM; (I«Preprésentant un atome de métal alcalin, en particulier le sodium), NK (CH2) ^ ~ COOC^Hg, NH - cycloalkyle, NH - phênyle, NH - benzyle (le radical benzy-le pouvant porter un substituant choisi parmi les atomes d'halogène et le radical trifluorométhyle) NH - alkyle, N - (alkyl)2, N - (alkyl) - (benzyl), les radicaux alkyles linéaires ou ramifiés ayant de 1 à 4 ato-! x / | n 2n • in which X ^ z and X ^, which are identical or different, each represent, independently of one another, a hydrogen or halogen atom, in particular chlorine -or fluorine , or a methyl radical! ! or methoxyl, n represents an integer at least equal to 1 and at most equal to 10 and, R represents a hydroxyl radical, OM, NH2, NH (CK2) COOH, -NH (CH2) 2 ~ COOM; (I "having an alkali metal atom, in particular sodium), NK (CH2) ^ ~ COOC ^ Hg, NH - cycloalkyle, NH - phenyle, NH - benzyle (the radical benzy-le being able to carry a substituent chosen among the halogen atoms and the trifluoromethyl radical) NH - alkyl, N - (alkyl) 2, N - (alkyl) - (benzyl), linear or branched alkyl radicals having from 1 to 4 ato-
KK
"mes ce carbone, les radicaux cycloalkyles ayant de 3 à 6 atomes de carbone, à l'exception du composé pour lequel - X^ - H, X2 = 5-Cl,n - 1 et R = OH."mes ce carbon, cycloalkyl radicals having 3 to 6 carbon atoms, with the exception of the compound for which - X ^ - H, X2 = 5-Cl, n - 1 and R = OH.
Les composés de la présente demande répondent à la formule (I)The compounds of the present application correspond to formula (I)
... i ^ J... i ^ J
t ! i /v /OR1 x2 / Cj - N - Cn H2n - C°-R (I) 0~^3 ' \ dans laquelle · ·t! i / v / OR1 x2 / Cj - N - Cn H2n - C ° -R (I) 0 ~ ^ 3 '\ in which · ·
* X X X et X* X X X and X
il7 2' 3 4 représentent chacun, indépendamment l'un de l’au- I- ! tre, un atome d’hydrogène ou d'halogène, un radical CH,, CH,0,il7 2 '3 4 each represents, independently of one of the- I-! tre, a hydrogen or halogen atom, a radical CH ,, CH, 0,
[S — J[S - J
j; J* no2, cf3, c(ch3]l3 ou ch3co nh, n représente un nombre entier allant de 1 à 10, R est un radical OH, OM (M = métal alcalin), NH2, NH-cycloalkyle, NH-phényle, NH-benzyle, NH-alkyle, N-(alkyl)2, N-(alkyl)-- J (benzyl), et i.'i R' représente un atome d'hydrogène ou un alkyle, jLès alkyles ayant de 1 à 4 atomes de carbone, ~ .* ^ j à l’exception des composés dans lesquels R'=H lorsque Χ^,Χ2 et ^3 sont chacun indépendamment l'un de l'autre H, Hal, CH3, CH30 et X4= 3 et du composé pour lequel R,;=H, X3=X3=X4=H, X2=Cl-5, n=l et R^OH.j; J * no2, cf3, c (ch3] l3 or ch3co nh, n represents an integer ranging from 1 to 10, R is an OH, OM (M = alkali metal), NH2, NH-cycloalkyl, NH-phenyl radical, NH-benzyl, NH-alkyl, N- (alkyl) 2, N- (alkyl) - J (benzyl), and i.'i R 'represents a hydrogen atom or an alkyl, jLès alkyl having from 1 to 4 carbon atoms, ~. * ^ J with the exception of the compounds in which R '= H when Χ ^, Χ2 and ^ 3 are each independently of each other H, Hal, CH3, CH30 and X4 = 3 and of the compound for which R,; = H, X3 = X3 = X4 = H, X2 = Cl-5, n = 1 and R ^ OH.
"I Un groupe de composés préférés est constitué par ceux dans les·*· quels R = OH, OM ou NH2 lorsque n est 3."I A group of preferred compounds is constituted by those in · * · which R = OH, OM or NH2 when n is 3.
Selon l'invention, on prépare les composés par réaction entre une cetone de formule (II)According to the invention, the compounds are prepared by reaction between a ketone of formula (II)
OHOH
X2X C = O (II) À“ ( et un composé de formule (III) NH- —CH- - CO-R (III) sous for- 2 n 2. n - -* me de base ou de chlorhydrate, et si on le désire, on alkyle ensuite les composés (I) obtenus dans lesquels R1 = H.X2X C = O (II) À “(and a compound of formula (III) NH- —CH- - CO-R (III) in the form 2 n 2. n - - * me of base or hydrochloride, and if if desired, then alkylate the compounds (I) obtained in which R1 = H.
• UJ3 i H...........• UJ3 i H ...........
‘ La réaction est effectuée dons un solvant alcoolique tel que le J i : ’méthanol ou l'éthanol, à une température allant de 10"C à la temoé- , i | · * I nature d'ébullition du solvant, en présence d'un métal alcalin ou «li ! hd'un alcoolato de métal alcalin.'The reaction is carried out in an alcoholic solvent such as J i:' methanol or ethanol, at a temperature ranging from 10 "C to temoé, i | · * I boiling nature of the solvent, in the presence of 'an alkali metal or' li! HD 'of an alkali metal alcoholato.
S II , ·S II, ·
Une variante de préparation des composés (I) detns lesquels R* = H et R est NH2 consiste à faire réagir une hydroxybenzephènene de formule (II) avec un composé I^N (CH2)n ^N, ^Cl (intermédiaire obtenu lors de la préparation du composé (illj ce formule ' H2N-(CH^ ) ^-CC-Xrb *- puis à effectuer une solvolyse du nitrile (IV) obtenu par condensatior * selon le schéma réactionnel suivant : _i™ [| + H2N-(CH2)n-CN, HCl -> ' ' j' C = °A variant for the preparation of the compounds (I) in which R * = H and R is NH2 consists in reacting a hydroxybenzephenene of formula (II) with a compound I ^ N (CH2) n ^ N, ^ Cl (intermediate obtained during the preparation of the compound (illj this formula 'H2N- (CH ^) ^ -CC-Xrb * - then to carry out a solvolysis of the nitrile (IV) obtained by condensatior * according to the following reaction scheme: _i ™ [| + H2N- ( CH2) n-CN, HCl -> '' j 'C = °
Ij-Q i .Ij-Q i.
X4_ .X4_.
OH - soit X OHOH - let X OH
î^-s_, ....î ^ -s_, ....
(ch2) nc« Jx^Vs- (ch,) -cc-Y:;-i ' 2 } soit 2 | -2 n 2 b —ί— |) (IV) H 0X1 --> - * HC1 S32 3 Ky * ~ \ Λ4 X.(ch2) nc "Jx ^ Vs- (ch,) -cc-Y:; - i '2} let 2 | -2 n 2 b —ί— |) (IV) H 0X1 -> - * HC1 S32 3 Ky * ~ \ Λ4 X.
44
Les composés de départ (III) et leur préparation sent déjà décrits dans la littérature.The starting compounds (III) and their preparation are already described in the literature.
i i !.i i !.
î ! S ' _ . · ! ; Les cetones (II) de départ --ml préparées - ’ ! i - l - - k , jl) soit a partir des ccmpQv.tg CH3î! S '_. ·! ; The starting ketones (II) - ml prepared - ’! i - l - - k, jl) or from ccmpQv.tg CH3
XlÎ> : . | ^ t ··-- par réaction avec un composé ; /~A_co Cl ‘ , ^ puis on déméthyle l’intermédiaire obtenu avec du chlorure d'aluminium ou du trichlorure de bore,XlÎ>:. | ^ t ·· - by reaction with a compound; / ~ A_co Cl ‘, ^ then demethylate the intermediate obtained with aluminum chloride or boron trichloride,
2) soit à partir des composés Λ O-CH2) either from the compounds Λ O-CH
:<r"ôC: <r "ôC
. X2 .V que l'on fait réagir avec un composé I ' · X4 > · et on hydrolyse l'intermédiaire pour obtenir un composé och3 I ! i Y^\. X2 .V which is reacted with a compound I '· X4> · and the intermediate is hydrolyzed to obtain a compound och3 I! i Y ^ \
i /-Lhe
I JI J
5 ! !! ! ! crue l'on déméthyle on car-rose (II) a l'aide de chlorure d'alumi-; nium ou de trichlorure de bore.5! !! ! ! raw one demethylated one car-rose (II) using aluminum chloride; nium or boron trichloride.
! .! .
Les cétones (II) sont nouvelles à l'exception de celles pour lesquelles X^, X3 sont chacun indépendamment l'un de l'autre H, -1 Hai, CH^, CH^O, C (CH^)^ lorsque X^= H. ... /The ketones (II) are new with the exception of those for which X ^, X3 are each independently of each other H, -1 Hai, CH ^, CH ^ O, C (CH ^) ^ when X ^ = H. ... /
Les cétones (II) nouvelles font partie de l'invention.The new ketones (II) are part of the invention.
La préparation des cétones (II) est illustrée dans les exemples de préparation des composés finals (I).The preparation of ketones (II) is illustrated in the examples of preparation of the final compounds (I).
vv
Les exemples suivants illustrent l'invention.The following examples illustrate the invention.
Les analyses et spectres IR et RMN confirment la structure des * composés.The IR and NMR analyzes and spectra confirm the structure of the * compounds.
Dans la présente demande sont également exemplifiés plusieurs composés qui répondent à la formule générale du brevet précédent (composés 24 à. 47) .In the present application are also exemplified several compounds which correspond to the general formula of the preceding patent (compounds 24 to. 47).
Exemple 1· N--phényl hydroxy-2 trifluorométhyl-5 benzylidé-nyl J-amino-4 butyrate de sodium.Example 1 · N - 2-phenyl hydroxy-5-trifluoromethyl benzylide-nyl J-4-amino sodium butyrate.
CF3-5 X2= X3= X4 = H R'= H R= ONa n = 3^ - 1. Hydroxy-2 trifluorométhyl-5 diphenyl-méthanone.CF3-5 X2 = X3 = X4 = H R '= H R = ONa n = 3 ^ - 1. 2-Hydroxy-5-trifluoromethyl-diphenyl-methanone.
l.‘l .. Dans un tricol de 250 ml, muni d'un réfrigérant ascendant et / d'une ampoule à brome, on introduit 1,68 g de magnésium (0,0691 mole] 25 ml d'éther anhydre et 1 cristal d'iode. On porte à reflux et introduit environ 10% d'une solution de 19,52 g de bromobenzène (0,1243 mole) dans 30 ml d'éther anhydre. Lorsque la réaction est bien démarrée, on introduit le reste de façon à maintenir le reflux. Après l'introduction, on porte à reflux jusqu'à disparition ; j ! 'totale du magnésium. Ensuite, on introduit de façon à mainte.-ir 3 c ! :: reflux 9,5 g (0,0472 jr.ole) de methoxy-2 trifluorcméthyl-5 fcenzoni- î ·l.'l .. 1.68 g of magnesium (0.0691 mol), 25 ml of anhydrous ether and 1 ml are added to a 250 ml three-necked flask, fitted with an ascending condenser and / with a dropping funnel. Iodine crystal, brought to reflux and introduced about 10% of a solution of 19.52 g of bromobenzene (0.1243 mole) in 30 ml of anhydrous ether. When the reaction is well started, the remainder is introduced. so as to maintain the reflux. After the introduction, the mixture is brought to reflux until disappearance; total magnesium. Then, it is introduced so as to maintain 3 r !: reflux 9.5 g ( 0.0472 jr.ole) of 2-methoxy-5-trifluorcethyl-5-benzenzi-
L ..6 JL ..6 J
: If'-’ I f: If'- ’I f
Ml ! ji trile dans 80 ml d'ëther anhydre puis on chauffe 4 heures à la ! ΐ i température de reflux. Ensuite on hydrolyse à froid et sous azote H avec 40 ml d*HCl 2N. Il se forme un précipité que l'on filtre, ! lave à l’éther et sèche. Il s'agit du chlorhydrate de j ! j j l'imine' ! j ^^°CH3 ! I >SvNH ; HC1Ml! ji trile in 80 ml of anhydrous ether and then heat for 4 hours! ΐ i reflux temperature. Then hydrolyzed cold and under nitrogen H with 40 ml of 2N HCl. A precipitate is formed which is filtered! wash with ether and dry. It is j hydrochloride! j j imine '! j ^^ ° CH3! I> SvNH; HC1
i r?3 JCi r? 3 JC
Ml (O) 'j On reprend ce chlorhydrate par 50 ml de toluène et 50 ml d'H2S04 { à. 25% et porte 8 heures a la température de reflux. On décante I alors la phase organique, la lave plusieurs fois à l'eau, sèche ! sur >igS04, filtre et évapore le toluène. On obtient la méthoxy-2 ! i trifluorométhyl-5 diphënyl-mëthanone · ' . Eb0,Q7=170°C·Ml (O) 'j This hydrochloride is taken up in 50 ml of toluene and 50 ml of H2SO4 {at. 25% and takes 8 hours at reflux temperature. The organic phase is decanted, washed several times with water, dried! on> igS04, filters and evaporates the toluene. We get methoxy-2! i 5-trifluoromethyl diphenyl-methanone · '. Eb0, Q7 = 170 ° C
1.2 Dans un flacon à réaction de 250 ml, on introduit 2,8g (1/1G0 mole)de msthoxy.-2 trifluoromethyl-5 diphênyl-mëthanone, 100 ml de I1.2 2.8 g (1 / 1G0 mole) of msthoxy.-2 trifluoromethyl-5 diphenyl-methanone, 100 ml of I are introduced into a 250 ml reaction flask.
chlorure de méthylène et l'on refroidit à -60°C. On introduit alors 10 g de trichlorure de bore et agite ensuite 1 heure à la température ambiante. On verse dans 1,5 1 d’eau glacée, ajoute 250 ml de chlorure de méthylène, agite, décante la phase organique, la lave 2 fois à l'eau, sèche sur 24gSO., filtre et éva- ! r * * ! pore le solvant.methylene chloride and cooled to -60 ° C. 10 g of boron trichloride are then introduced and the mixture is then stirred for 1 hour at room temperature. Pour into 1.5 1 of ice water, add 250 ml of methylene chloride, stir, decant the organic phase, wash it twice with water, dry over 24gSO., Filter and eva-! r * *! pore the solvent.
| On obtient des cristaux jaune clair que l'on recristallise dans de t t| Clear yellow crystals are obtained which are recrystallized from t t
| l'éther de pétrole avec traitement au charbon végétal. On obtient I l'hyâroxy-2 trifluorcméthvl-5 diphenyl-méthanone qui fond à 84-85c‘C| petroleum ether with vegetable charcoal treatment. We get I 2-hydroxy-trifluorcmethvl-5 diphenyl-methanone which melts at 84-85c‘C
2. N-jj>{-phényl hydroxy-2 trifluorométhyl-5 benzylidénylJ-aminc-4 butyrate de sodium.2. N-jj> {- phenyl hydroxy-2-trifluoromethyl-5 benzylidenylJ-4-aminc sodium butyrate.
Dans un ballon de 1 1, on introduit 1,15 g d:acide amino-4 butyrique à 97%, 300 ml de méthanol et 0,62 g de méthylate de sodium et l'or agite 2 à 3 mn. On introduit alors 2,8 g d1hydroxy-2 trifluorométhyl-5 diohénylméthanone et 300 ml d'éthanol. On évaoore à la ί * | pression atmosphérique (100°C). On évapore enfin la totalité du < _ / • ] r * ' ............. r ’ * ...........1.15 g of 4% amino-butyric acid 97%, 300 ml of methanol and 0.62 g of sodium methylate are introduced into a 1-liter flask and the gold stirred for 2 to 3 min. 2.8 g of 2-hydroxy-5-trifluoromethyl-diohenylmethanone and 300 ml of ethanol are then introduced. We evaporate at the ί * | atmospheric pressure (100 ° C). Finally, we evaporate the entire <_ / •] r * '............. r ’* ...........
d'eau froide. On acidifie à pH~4 par-de l'acide citrique, extrait | · au chloroforme, sèche la phase'chloroformique sur MgSO^, filtre ! et évapore le chloroforme. On obtient une huile qui cristallise dans de 1'éther de pétrole. On filtre, essore, lave à l'éther de pétrole, essore et recristallise dans de l'éther avec traitement au charbon végétal. On obtient l'acide qui fond à 154-155°C.of cold water. Acidified to pH ~ 4 with citric acid, extract | · With chloroform, dry the chloroform phase on MgSO ^, filter! and evaporates the chloroform. An oil is obtained which crystallizes from petroleum ether. It is filtered, drained, washed with petroleum ether, filtered and recrystallized from ether with treatment with vegetable charcoal. The acid is obtained which melts at 154-155 ° C.
i i On dissout 2,5 g d'acide dans 150 ml de méthanol et ajoute 0,38 g i ί de mëthylate de sodium. On évapore à sec et obtient le sel de sodium que l'on sèche 1 heure à 80°C au dessicateur.i i 2.5 g of acid are dissolved in 150 ml of methanol and 0.38 g i ί of sodium methylate is added. Evaporated to dryness and the sodium salt is obtained which is dried for 1 hour at 80 ° C. in a desiccator.
P = 216-217°C.P = 216-217 ° C.
3 ' ·' Exemple 2 N-jX - (dichloro-2 ', 4 ' phényl) chloro-5 hydroxy-2 benzylidénylJamino-4 butyramide.3 '·' Example 2 N-jX - (2-dichloro ', 4' phenyl) 5-chloro-2-hydroxy-benzylidenylJamino-4 butyramide.
·’ [x = Cl-5 X2= H X3= Cl-2 ' X4= Cl-4' R= NH2 R’= H n = 3j - ✓ 1. Hydroxy-2 trichloro-2',4',5 diphénylméthanone.· '[X = Cl-5 X2 = H X3 = Cl-2' X4 = Cl-4 'R = NH2 R' = H n = 3j - ✓ 1. Hydroxy-2 trichloro-2 ', 4', 5 diphenylmethanone .
1.1 A une solution agitée et portée à la température de reflux de 25,7 g de p-chlorophénol et de 30,3 g de triéthylamine dans 1.2 1 d'éther, on ajoute lentement, une solution éthérée de chlorure de dichloro-2,4 benzoyle. Puis on chauffe à la température de1.1 To an agitated solution brought to the reflux temperature of 25.7 g of p-chlorophenol and 30.3 g of triethylamine in 1.2 1 of ether, an ethereal solution of 2-dichloro chloride is added slowly, 4 benzoyl. Then we heat to the temperature of
NNOT
reflux, en agitant pendant 3 heures et laisse les produits en contact pendant la nuit. On filtre le précipité de Et3N,HCl et le ' lave à l'éther. La phase organique est lavée à l'eau, à l'eau bicarbonatée et à l'eau. On sèche sur MgSO^, filtre et concentre au 3/4 environ. Le dichloro-2,4 benzoate de p-chlorophényle précipite.reflux, stirring for 3 hours and leaving the products in contact overnight. The Et3N, HCl precipitate is filtered and washed with ether. The organic phase is washed with water, bicarbonate water and water. It is dried over MgSO 4, filtered and concentrated to about 3/4. 2,4-dichloro benzoate p-chlorophenyl precipitates.
. On refroidit, filtre, essore et sèche au dessicateur chauffant à 6§°C.. Cool, filter, spin dry and dry in a heated desiccator at 6 ° C.
F = 124-125°C.Mp 124-125 ° C.
1.2 On chauffe 35,5 g de l'ester précédent jusqu'à fusion. On agite et ajoute 35,5 g de AlCl^. Puis on chauffe jusqu'à 190° et agite pendant 15 mn à cette température. Après refroidissement, on broie le résidu et l'hydrolyse. On le verse en agitant dans 800 g d'un mélange d'eau + glace + 100 ml d'acide chlorhydrique concentré.1.2 35.5 g of the above ester are heated until fusion. Stir and add 35.5 g of AlCl 4. Then heated to 190 ° and stirred for 15 min at this temperature. After cooling, the residue is ground and hydrolysis. It is poured with stirring into 800 g of a mixture of water + ice + 100 ml of concentrated hydrochloric acid.
Puis on extrait au chloroforme, sèche sur MgSO^, filtre et évapore à sec. On recristalllse dans de l'éther de pétrole, essore et π ^ n T*\ a » .J m . J_ >> .· u T ^ ___- J .. J X. JC _ . _ Ä Λ /“ A T Ο Λ ί j ! Ιί.......T ; ' , ! ·. 2. Η·-* ^- (dichloxo-2 *, 4 * phényl) chloro-5 hydroxy~2 benzylidénylj- j j u ·* .Then extracted with chloroform, dried over MgSO 4, filtered and evaporated to dryness. Recrystallized from petroleum ether, drained and π ^ n T * \ a ".J m. J_ >>. · U T ^ ___- J .. J X. JC _. _ Ä Λ / “A T Ο Λ ί j! Ιί ....... T; ',! ·. 2. Η · - * ^ - (dichloxo-2 *, 4 * phenyl) chloro-5 hydroxy ~ 2 benzylidenylj- j j u · *.
| ·; ~amino--4 butyramide.| ·; ~ amino - 4 butyramide.
. i * I * • On évapore à sec, une solution de 12,3 g de la cétone obtenue sous i 1/ 5,3 g de ^-amino-butyramide sous forme de chlorhydrate et 2,4 ç de MeONa dans 500 ml de méthanol.. i * I * • Evaporated to dryness, a solution of 12.3 g of the ketone obtained in i 1 / 5.3 g of ^ -amino-butyramide in the form of hydrochloride and 2.4 ç of MeONa in 500 ml of methanol.
Ansuite on évapore 4 fois de suite 350 ml d'alcool et on termine | les 2 dernières évaporations sous pression réduite. Le résidu est ! ; dissous dans CHCl-j. On lave à l'eau , sèche sur MgSO^, filtre et | évapore à sec. Le résidu cristallise dans de l'éther. On filtre i j < . | sur fritté et essore. On traite ensuite au charbon dans du méthane ! j I filtre et évaoore à. sec. On recristallise dans de l'alcool, filtreAnsuite we evaporate 350 ml of alcohol 4 times in a row and we finish | the last 2 evaporations under reduced pressure. The residue is! ; dissolved in CHCl-j. Wash with water, dry over MgSO 4, filter and | evaporates to dryness. The residue crystallizes from ether. We filter i j <. | on sintered and wrung. We then treat with charcoal in methane! j I filter and evaporate at. dry. We recrystallize from alcohol, filter
! j I! j I
< =- :j lave à l'éther, essore et sèche au dessicateur chauffant.<= -: j wash with ether, spin and dry in a heated desiccator.
' | ‘ F = 141-142°C.'| ‘F = 141-142 ° C.
'Exemple 3 Acide -(chloro-4’phenyl) tertiobutyl-5 hydroxy- benzylidénylJ - amino-4 butyrique.Example 3 Acid - (4-chloro-phenyl) 5-tert-butyl hydroxy-benzylidenylJ - 4-amino butyric acid.
fx. = C(CHj_-5 = H X = Cl-41 X. = H n = 3' u 1 3 3 2 3 4 R* = H R = oa] 1. Tertiobutyl - 5 chloro - 4' hydroxy - 2 diphényl-méthanone.fx. = C (CHj_-5 = H X = Cl-41 X. = H n = 3 'u 1 3 3 2 3 4 R * = H R = oa] 1. Tertiobutyl - 5 chloro - 4' hydroxy - 2 diphenyl-methanone.
* i 1.1 A 120 g. de p.tertiobutyl-anisole dans 1 £0 ml. de te'tra-. ’ . chloro éthane, on ajoute en agitant 128 g. de chlorure de i p.chloro-benzoyle et 0,25 g de ZnCl^ fraîchement fondu et broyé. Puis, on chauffe à 140°C, en agitant, pendant 40 h.* i 1.1 At 120 g. of p.tertiobutyl-anisole in 1 lb 0 ml. of tetra-. ’. chloroethane, added with stirring 128 g. of chloro-benzoyl chloride and 0.25 g of freshly ground and ground ZnCl 4. Then, the mixture is heated to 140 ° C., with stirring, for 40 h.
Ensuite, on évapore le solvant et distille sous pression .Then the solvent is evaporated and distilled under pressure.
$ réduite. Le distillât cristallise dans de l'éther de pétroc . le. On recristallise la t-butyl-5 chloro-41 méthoxy-2 di- phényl-méthanone dans de l'éther de pétrole avec traitement au charbon végétal.$ reduced. The distillate crystallizes in petroc ether. the. The t-butyl-5-chloro-41-methoxy-2-phenphenyl-methanone is recrystallized from petroleum ether with treatment with vegetable charcoal.
F 46 - 47°CF 46 - 47 ° C
'i . * ' * \ .-¾ .1.2 A 88g du composé obtenu précédemment dans 150 ml de benzène on ajoute, en agitant, 46,3 g de Aie 1^ et on chauffe à 70°, pendant 12h. Puis, après refroidissement, on hydrolyse en versant sur de la glace et de l'acide chlorhydrique concentré et en agitant. On décante, lave à l'eau, sèche sur Mgso./ filtre et évapore à sec. Le résidu cristallise * » dans de l'éther de pétrole. On filtre sur fritté, essore et recristallise dans du inéthanol avec traitement au charbon végétal. On sèche au dessiccateur.'i. * '* \.-¾ .1.2 To 88 g of the compound obtained above in 150 ml of benzene is added, with stirring, 46.3 g of Aie 1 ^ and the mixture is heated at 70 °, for 12 hours. Then, after cooling, the mixture is hydrolyzed by pouring onto ice and concentrated hydrochloric acid and stirring. Decanted, washed with water, dried over Mgso./ filter and evaporated to dryness. The residue crystallizes * "in petroleum ether. Filtered on sintered, drained and recrystallized from inethanol with treatment with vegetable charcoal. It is dried in a desiccator.
-’ F 64 - 65°C- ’F 64 - 65 ° C
2. Acide N - (chloro - 4' phênyl)tertiobutyl-5 hydroxy-2 benzylidényl ^-amino-4 butyrique.2. N - (4 'chloro-phenyl) tert-butyl-5-hydroxy-2-benzylidenyl-4-amino-butyric acid.
On évapore à sec une solution de 5,4 g. d'acide amino-4 butyrique, 3g de MeoNa et 15,4g. de la cétone obtenue précédemment dans 500 ml de inéthanol et 300 ml d'alcool. On ajoute 600 ml d'alcool et évapore à sec, en terminant sous pression réduite. On recommence 2 fois cette opération. On dissout let résidu dans de l'eau acidifiéeà pH 4 avec de l'acide citrique.A 5.4 g solution is evaporated to dryness. 4-amino butyric acid, 3g of MeoNa and 15.4g. ketone obtained previously in 500 ml of inethanol and 300 ml of alcohol. 600 ml of alcohol are added and evaporated to dryness, finishing under reduced pressure. This operation is repeated twice. The residue is dissolved in acidified water to pH 4 with citric acid.
{ On extrait au chloroforme, sèche sur MgSO., filtre et évapore .-J· à sec. Le précipité obtenu est entraîné sur fritté avec de j l'éther de pétrole. On recristallise dans de l'acétate d'éthy- ! le avec traitement au charbon végétal. On sèche au dessicateur j chauffant.{Extracted with chloroform, dried over MgSO., Filtered and evaporated. -J · to dryness. The precipitate obtained is entrained on a frit with petroleum ether. We recrystallize from ethyl acetate! with treatment with vegetable charcoal. It is dried in a heated desiccator.
I - F 140 - 141°CI - F 140 - 141 ° C
i * · 1 ί . !· i * .i * · 1 ί. ! · I *.
«· . Exemple 4 N--(chloro-4'phênyl) fluoro-5 méthoxy-2 benzyli- dënylJ-amino-4 butyramide."·. Example 4 N - (4-chloro-phenyl) 5-fluoro-2-methoxy-benzylidenyl-4-amino-butyramide.
£χχ = F-5 X3 = Cl-4 ' X2 = X4 = H R = NH2 R' = CH3£ χχ = F-5 X3 = Cl-4 'X2 = X4 = H R = NH2 R' = CH3
n = ?Jn =? J
On évapore à sec une solution de 3,4 g de N-J^-(chloro-4' phênyl) fluoro-5 hydroxy-2 benzylidénylJ-amino-4 butyramide et de 0,55 g de méthylate de sodium dans 150 ml de méthanol. Puis on sèche au dessicateur chauffant à 120°.A solution of 3.4 g of N-J ^ - (4-chloro-phenyl) fluoro-5-hydroxy-2-benzylidenylJ-amino-4-butyramide and of 0.55 g of sodium methylate in 150 ml of methanol is evaporated to dryness. Then dry with a drying dryer at 120 °.
Après refroidissement le résidu est dissous dans 100 ml ce DMSOAfter cooling the residue is dissolved in 100 ml this DMSO
Π!.........7..............—' ..................: '.....................'.............:........~ ; Ί Γ On agite et introduit, goutte à goutte, clans la solütion agitee,Π! ......... 7 ..............— '..................:' .. ...................'.............: ........ ~; Ί Γ Shake and introduce, drop by drop, into the stirred solution,
; i I; i i
• I J• I J
. i ! i 3 g d'icdure de méthyle dans 25 ml de DMSO. Puis on agite à la j j ; ! jj température ambiante pendant 30 mn.. i! i 3 g of methyl chloride in 25 ml of DMSO. Then we stir at j j; ! dd room temperature for 30 min.
i j On évapore à sec, sous pression réduite, dissout le résidu dans j i · " | 200 ml de chloroforme, lave à l'eau, sèche et évapore à sec.i j Evaporate to dryness under reduced pressure, dissolve the residue in j i · "| 200 ml of chloroform, wash with water, dry and evaporate to dryness.
j Le.résidu est entraîné sur fritté avec de l'éther. On recristalli-· j .The residue is entrained on a frit with ether. We recrystallize.
j se le produit dans de l'alcool, le lave à l'acétone et à l'éther, ! l’essore et le sèche au dessicateur chauffant.j occurs in alcohol, washes with acetone and ether,! wring it out and dry it in a heated desiccator.
F = 154/5-155/50C... _ }> j Dans le tableau suivant sont représentés les composés préparés à i j ! j , titre d'exempless-illustrant la'formule (I).F = 154 / 5-155 / 50C ... _}> j The following table shows the compounds prepared at i j! j, title of examples-illustrating the formula (I).
« . * --s i i .". * --s i i.
I \ c * é t-I \ c * e t-
. L ’ >. J. The>. J
..................“................_.................................................................. “................_.............. ..................................
TABLEAU ITABLE I
Composé X3 X^ n R R1 F(°C) 1 ’ N02~5 H Cl-A* H 3 OH H 240 (dec) 2 . :H3CO NH-5 H HH 3 KH2 H 240 (dec) - '3 CF3-5 Ή- VCF3-4' H 3 * ONa h 238 (dec) 4 . CF3-5 H cf3~3' h 3 0Na H 218 (dec) 5- ' cf3-5 h’ cf3“4' H 3 NH2 H 119,6 6. CF3-5 H cf3~3' H 3 NH2 H 98,7 , 7 ’ ÇF-,-5 H F-4 ' H 3 OH H 173,5 • ! j ~ ·" ' ONa ‘ H > 250 : : "j 8 n02-5 H Cl-4' h 3 NH2 H 172,5 ; ! I 9 CF3'5 h F-4' H 3 NH_ H 120,6 ! 1 ° 2 ! ! 10 - F-5 H N02-47 h 3 OH H 169-70 [ i ONa H 180 (dec) ! ’ 11 - F“5 H NO„-4' H 3 NH0 H 190-1 1 j 2 2 I I 12 CF3~3 H h h 3 OH H 154-5 ! J ,0 ONa H 216 (dec) I J 13 cf3 5 H H H 3 H H 2 H 93-94 ! ! 24 CÎCH3)3“5 h c1“4/ H 3 OH H 140-1 I j i - 15 C(CH3)3-5 H Cl-4' H -3 NH2 H 121-2 J 16 N02-5 HH H 3 OH H 177-8 I ONa H 227 (dec) 17 NO -5 HH H 3 NHL H 185-6 I , 2 I ' j 18 C^CH3^3~5 H H H 3 NH2 H 135-6 ! ; 19· C(CH3^3“5 h H h 3 OH h 131-2 :20 * C1-5 H Cl-4' Cl-2/ 3 NH 2 H 141-2 j 21 Cl-5 H Cl-4' C1-2V 3 CH H 172-4 I ONa H 245(dec) |22 F“5 H ΟΓ3~4’ K 3 \NH2 H 151-2 - ; ' 23 F~5 H Cl-4» H . -X . KK2 CH3 1S5- •24 Cl-5 H Br-41 H 3 ~NH? 169-170 25 Br-5 H Cl-4' H 3 NK2 H 15 6-157 26 Br-5 'H H H 3 NH2 H 134-135 27 Br-5 H Br-4' H 3 ΝΗ? H 164,5--166^ 28 F-5 H Cl-21 H 3 CH H 85,5-87Compound X3 X ^ n R R1 F (° C) 1 ’N02 ~ 5 H Cl-A * H 3 OH H 240 (dec) 2. : H3CO NH-5 H HH 3 KH2 H 240 (dec) - '3 CF3-5 Ή- VCF3-4' H 3 * ONa h 238 (dec) 4. CF3-5 H cf3 ~ 3 'h 3 0Na H 218 (dec) 5-' cf3-5 h 'cf3 “4' H 3 NH2 H 119.6 6. CF3-5 H cf3 ~ 3 'H 3 NH2 H 98 , 7, 7 'ÇF -, - 5 H F-4' H 3 OH H 173.5 •! j ~ · "'ONa‘ H> 250:: "j 8 n02-5 H Cl-4' h 3 NH2 H 172.5; ! I 9 CF3'5 h F-4 'H 3 NH_ H 120.6! 1 ° 2! ! 10 - F-5 H N02-47 h 3 OH H 169-70 [i ONa H 180 (dec)! ’11 - F“ 5 H NO „-4 'H 3 NH0 H 190-1 1 d 2 2 I I 12 CF3 ~ 3 H h h 3 OH H 154-5! J, 0 ONa H 216 (dec) I J 13 cf3 5 H H H 3 H H 2 H 93-94! ! 24 CÎCH3) 3 “5 h c1“ 4 / H 3 OH H 140-1 I ji - 15 C (CH3) 3-5 H Cl-4 'H -3 NH2 H 121-2 J 16 N02-5 HH H 3 OH H 177-8 I ONa H 227 (dec) 17 NO -5 HH H 3 NHL H 185-6 I, 2 I 'j 18 C ^ CH3 ^ 3 ~ 5 HHH 3 NH2 H 135-6! ; 19 · C (CH3 ^ 3 “5 h H h 3 OH h 131-2: 20 * C1-5 H Cl-4 'Cl-2/3 NH 2 H 141-2 j 21 Cl-5 H Cl-4' C1-2V 3 CH H 172-4 I ONa H 245 (dec) | 22 F “5 H ΟΓ3 ~ 4 'K 3 \ NH2 H 151-2 -;' 23 F ~ 5 H Cl-4” H. -X .KK2 CH3 1S5- • 24 Cl-5 H Br-41 H 3 ~ NH? 169-170 25 Br-5 H Cl-4 'H 3 NK2 H 15 6-157 26 Br-5' HHH 3 NH2 H 134- 135 27 Br-5 H Br-4 'H 3 ΝΗ? H 164.5--166 ^ 28 F-5 H Cl-21 H 3 CH H 85.5-87
K IK I
°H° H
! xi-ÇjT! xi-ÇjT
x/^^c = 0 . (II) 2 0-· .x / ^^ c = 0. (II) 2 0- ·.
x„ 4 ! javec un composé de formule (IV) NH —C H0 -COR 2 n 2n !sous forme de base ou de chlorhydrate,, et, si on le désire, on p jalkyle ensuite les composés (I) obtenus dans'lesquels R»-H pour - ' -préparer les composés (I) dans lesquels R'=alhyle, les radicaux ayant les significations données dans la revendication ! 15. Médicament caractérisé en ce qu'il contient un composé tel que ! t · ! ! ^spécifié dans l’une quelconque des revendications 1 à 3; 6. Cétones nécessaires comme intermédiaires pour la préparation des! composés de formule (IJ» répondant a la formule.(Il)x „4! jwith a compound of formula (IV) NH —C H0 -COR 2 n 2n! in the form of a base or of hydrochloride, and, if desired, the compounds (I) obtained in'lesquels R ”- are then alkylated - H for - '- prepare the compounds (I) in which R' = alkyl, the radicals having the meanings given in claim! 15. Medicine characterized in that it contains a compound such as! t ·! ! ^ specified in any one of claims 1 to 3; 6. Ketones needed as intermediates for the preparation of! compounds of formula (IJ "corresponding to the formula. (II)
OHOH
jfYjfY
Xr10Ac - o un 4 Γ • : | . 'dans laquelle X4 X^, X2, X^ et X4 représentent chacun indépendamment l'un de l’autre !un atome d’hydrogène ou d’halogène, un radical CH , CH^O, N02, CF3, c(ch3)3 ou ch3co NH, à 1’exception des composés pour lesquels X^, X , X3 sont chacun indépendamment l'un de l'autre H, Hal, CK3, CH^O, lorsque x4 - \ ·, l ’ ' \ f 1 - v-Xr10Ac - o un 4 Γ •: | . in which X4 X ^, X2, X ^ and X4 each independently of one another! a hydrogen or halogen atom, a radical CH, CH ^ O, NO2, CF3, c (ch3) 3 or ch3co NH, with the exception of the compounds for which X ^, X, X3 are each independently of each other H, Hal, CK3, CH ^ O, when x4 - \ ·, l '' \ f 1 - v-
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7805578A FR2418222A2 (en) | 1975-08-01 | 1978-02-27 | Alpha-phenyl 2-hydroxy-benzylidene amino-alkanoic acid derivs. - and novel di:phenyl-ketone intermediates, useful as anticonvulsants for treating epilepsy |
| FR7805578 | 1978-02-27 | ||
| FR7820940A FR2430936A1 (en) | 1978-07-13 | 1978-07-13 | Alpha-phenyl 2-hydroxy-benzylidene amino-alkanoic acid derivs. - and novel di:phenyl-ketone intermediates, useful as anticonvulsants for treating epilepsy |
| FR7820940 | 1978-07-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU80974A1 true LU80974A1 (en) | 1980-09-24 |
Family
ID=26220461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU80974A LU80974A1 (en) | 1978-02-27 | 1979-02-27 | BENZYLIDENIC DERIVATIVES |
Country Status (20)
| Country | Link |
|---|---|
| JP (1) | JPS54125644A (en) |
| AT (1) | AT365564B (en) |
| AU (1) | AU520618B2 (en) |
| BE (1) | BE874488A (en) |
| CA (1) | CA1119613A (en) |
| CH (1) | CH637112A5 (en) |
| DE (1) | DE2907379A1 (en) |
| DK (1) | DK82079A (en) |
| ES (1) | ES478070A1 (en) |
| FI (1) | FI790656A7 (en) |
| GB (1) | GB2021559B (en) |
| GR (1) | GR66971B (en) |
| IE (1) | IE47930B1 (en) |
| IT (1) | IT1113010B (en) |
| LU (1) | LU80974A1 (en) |
| NL (1) | NL7901474A (en) |
| NO (1) | NO790646L (en) |
| NZ (1) | NZ189769A (en) |
| PT (1) | PT69288A (en) |
| SE (1) | SE7901706L (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0047516B1 (en) * | 1980-09-04 | 1984-01-04 | Toray Industries, Inc. | Propylamine derivative and process of manufacturing the same |
| JPS5746951A (en) * | 1980-09-04 | 1982-03-17 | Toray Ind Inc | Production of 2-amino-4-cyanobutyric derivative |
| FR2536746A1 (en) * | 1982-11-29 | 1984-06-01 | Synthelabo | ALKYL BENZYLIDENIC DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| FR2544308B1 (en) * | 1983-04-14 | 1985-06-14 | Synthelabo | SUBSTITUTED ETHINS, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS |
| DE68907857T2 (en) * | 1988-11-03 | 1993-12-23 | Fournier Ind Et Sante Paris | Beta-D-phenylthioxyloside, process for their preparation and their use as medicines. |
| WO1991007380A1 (en) * | 1989-11-08 | 1991-05-30 | Dunlena Pty. Ltd. | Arthropodicides |
| JP2005232103A (en) * | 2004-02-20 | 2005-09-02 | Nagase & Co Ltd | Optically active vicinaldiamine and method for producing the same |
-
1979
- 1979-02-26 SE SE7901706A patent/SE7901706L/en not_active Application Discontinuation
- 1979-02-26 NL NL7901474A patent/NL7901474A/en active Search and Examination
- 1979-02-26 DK DK82079A patent/DK82079A/en not_active Application Discontinuation
- 1979-02-26 PT PT69288A patent/PT69288A/en unknown
- 1979-02-26 NZ NZ189769A patent/NZ189769A/en unknown
- 1979-02-26 AU AU44602/79A patent/AU520618B2/en not_active Ceased
- 1979-02-26 CH CH188579A patent/CH637112A5/en not_active IP Right Cessation
- 1979-02-26 JP JP2247179A patent/JPS54125644A/en active Pending
- 1979-02-26 NO NO790646A patent/NO790646L/en unknown
- 1979-02-26 IT IT20543/79A patent/IT1113010B/en active
- 1979-02-26 ES ES478070A patent/ES478070A1/en not_active Expired
- 1979-02-26 DE DE19792907379 patent/DE2907379A1/en not_active Withdrawn
- 1979-02-27 GB GB7906963A patent/GB2021559B/en not_active Expired
- 1979-02-27 FI FI790656A patent/FI790656A7/en not_active Application Discontinuation
- 1979-02-27 BE BE0/193728A patent/BE874488A/en not_active IP Right Cessation
- 1979-02-27 LU LU80974A patent/LU80974A1/en unknown
- 1979-02-27 CA CA000322406A patent/CA1119613A/en not_active Expired
- 1979-02-27 AT AT0149179A patent/AT365564B/en not_active IP Right Cessation
- 1979-02-27 GR GR58490A patent/GR66971B/el unknown
- 1979-08-08 IE IE556/79A patent/IE47930B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK82079A (en) | 1979-08-28 |
| IE790556L (en) | 1979-08-27 |
| JPS54125644A (en) | 1979-09-29 |
| IT1113010B (en) | 1986-01-20 |
| NL7901474A (en) | 1979-08-29 |
| SE7901706L (en) | 1979-08-28 |
| FI790656A7 (en) | 1979-08-28 |
| AT365564B (en) | 1982-01-25 |
| ES478070A1 (en) | 1979-07-01 |
| NZ189769A (en) | 1981-07-13 |
| GB2021559B (en) | 1982-07-07 |
| AU520618B2 (en) | 1982-02-11 |
| IE47930B1 (en) | 1984-07-25 |
| GR66971B (en) | 1981-05-15 |
| CA1119613A (en) | 1982-03-09 |
| DE2907379A1 (en) | 1979-09-06 |
| CH637112A5 (en) | 1983-07-15 |
| ATA149179A (en) | 1981-06-15 |
| AU4460279A (en) | 1979-09-06 |
| IT7920543A0 (en) | 1979-02-26 |
| PT69288A (en) | 1979-03-01 |
| GB2021559A (en) | 1979-12-05 |
| BE874488A (en) | 1979-08-27 |
| NO790646L (en) | 1979-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2429268C (en) | 2-butyl-3-(4-[3(dibutylamino)propoxy]benzoyl)-5-nitro-benzofuranhydrochloride and its preparation | |
| CH620415A5 (en) | ||
| EP0459887A1 (en) | Pyrazole-orthodialkyl-benzamide derivatives with an anticonvulsive activity, process for preparation and pharmaceutical composition | |
| US5192797A (en) | Derivatives of 2-aminoalkyl-5-arylalkyl-1,3-dioxanes, their preparation and their therapeutic application | |
| LU80974A1 (en) | BENZYLIDENIC DERIVATIVES | |
| FR2479821A1 (en) | N4-CARBAMOYLPIPERAZINOPROPANOL DERIVATIVES USEFUL FOR THEIR ADRENALINE B-BLOCKING ACTIVITY | |
| EP0094102B1 (en) | 1-(1-cyclohexanyl-methyl) pyrrolidine derivatives, and process for their preparation | |
| FR2628105A1 (en) | ACYLPHENOL DERIVATIVES | |
| CH661509A5 (en) | AROMATIC KETONES. | |
| CH464172A (en) | Process for the preparation of -substituted carboxylic acids | |
| FR2781797A1 (en) | ANTIDIABETIC PIPERAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
| CH615414A5 (en) | ||
| EP0694029B1 (en) | Novel method for preparing beta-alkoxy acrylic acid | |
| Meiresonne et al. | Synthesis of novel β-aminocyclobutanecarboxylic acid derivatives by a solvent-free aza–Michael addition and subsequent ring closure | |
| CA1109885A (en) | Process for the preparation of 2-methyl-2-phenoxy- propionic acid derivatives | |
| CH617173A5 (en) | ||
| MC598A1 (en) | New chemical compounds and process for their preparation | |
| US3647874A (en) | N-cyanobenzoylhaloalkylsulfonanilides | |
| CA1044697A (en) | Novel disubstituted azabicycloalcanes | |
| EP0057141B1 (en) | Esters of halogene-biphenylcarboxylates, method of preparation and their application as medicines | |
| FR2663330A1 (en) | 2-Aminoalkyl-5-arylalkyl-1,3-dioxane derivatives, their preparation and application in therapeutics | |
| JPH041736B2 (en) | ||
| CH393364A (en) | Process for the preparation of new acetanilide derivatives | |
| FR2483419A1 (en) | PROCESS FOR THE PREPARATION OF N- (2- (2-THENOYL) -THIOPROPIONYL) -GLICINE | |
| JPH0749410B2 (en) | Method for producing 3,3-dichloroacrylonitrile |